A new trading day began on Friday, with Legend Biotech Corp ADR (NASDAQ: LEGN) stock price down -4.26% from the previous day of trading, before settling in for the closing price of $39.89. LEGN’s price has ranged from $38.60 to $70.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 50.60%. Meanwhile, its annual earnings per share averaged 45.17%. With a float of $181.94 million, this company’s outstanding shares have now reached $183.45 million.
Considering the fact that the conglomerate employs 1826 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 57.85%, operating margin of -76.2%, and the pretax margin is -62.95%.
Legend Biotech Corp ADR (LEGN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Legend Biotech Corp ADR is 0.93%, while institutional ownership is 49.80%. The most recent insider transaction that took place on Sep 25 ’24, was worth 66,326. Before that another transaction happened on Sep 20 ’24, when Company’s Officer proposed sale 90,060 for $48.91, making the entire transaction worth $4,405,003.
Legend Biotech Corp ADR (LEGN) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.8 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 45.17% per share during the next fiscal year.
Legend Biotech Corp ADR (NASDAQ: LEGN) Trading Performance Indicators
Here are Legend Biotech Corp ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Legend Biotech Corp ADR (LEGN)
Compared to the last year’s volume of 1.1 million, its volume of 1.7 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 6.73%. Additionally, its Average True Range was 2.25.
During the past 100 days, Legend Biotech Corp ADR’s (LEGN) raw stochastic average was set at 0.74%, which indicates a significant decrease from 1.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.94% in the past 14 days, which was lower than the 49.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $46.01, while its 200-day Moving Average is $51.19. Nevertheless, the first resistance level for the watch stands at $39.38 in the near term. At $40.57, the stock is likely to face the second major resistance level. The third major resistance level sits at $41.25. If the price goes on to break the first support level at $37.51, it is likely to go to the next support level at $36.83. Should the price break the second support level, the third support level stands at $35.64.
Legend Biotech Corp ADR (NASDAQ: LEGN) Key Stats
With a market capitalization of 7.01 billion, the company has a total of 182,305K Shares Outstanding. Currently, annual sales are 285,140 K while annual income is -518,250 K. The company’s previous quarter sales were 186,520 K while its latest quarter income was -18,200 K.
